Fundraising Fox
RADiCAIT
Techstars '24London, GB · 2 known investors
Find your way into RADiCAIT
Sign up to see every warm intro you have to RADiCAIT
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RADiCAIT team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RADiCAIT develops Insilico PET, an AI-powered technology that transforms routine CT scans into functional disease activity maps without requiring radioactive tracers or additional hardware, enabling faster and more accessible diagnostic imaging at scale.
Founders & leadership
DS
Dr Seán WalshCEO
DR
Dr Regent LeeCMIO
DS
Dr Sina ShahendehCTO
JS
JP SampsonCOO
Investors · 2
Frequently asked questions
- What does RADiCAIT do?
- RADiCAIT develops Insilico PET, an AI-powered technology that transforms routine CT scans into functional disease activity maps without requiring radioactive tracers or additional hardware, enabling faster and more accessible diagnostic imaging at scale.
- Who are RADiCAIT's investors?
- RADiCAIT's investors include Frontline Ventures, Techstars.
- Where is RADiCAIT headquartered?
- RADiCAIT is headquartered in London, GB.